Literature DB >> 1423605

Differentiation of an immature T cell line: a model of thymic positive selection.

J Kaye1, D L Ellenberger.   

Abstract

Thymocyte differentiation is dependent upon recognition of major histocompatibility complex (MHC) molecules on thymic stroma, a process called positive selection. Here we describe an immature CD4+8+ T cell line derived from a TCR transgenic mouse that differentiates into CD4+8- cells in response to antigen and nonthymic antigen-presenting cells. When injected intrathymically, these cells differentiate in the absence of antigen. The ability of immature T cells to recognize MHC molecules in the absence of foreign antigen in the thymus can thus be attributed to a unique property of thymic antigen-presenting cells. These studies also demonstrate the phenotypic and functional changes associated with TCR-mediated T cell maturation and establish an in vitro model system of positive selection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1423605     DOI: 10.1016/0092-8674(92)90512-b

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  15 in total

Review 1.  Regulation of T cell development in the thymus.

Authors:  J Kaye
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Class II-positive hematopoietic cells cannot mediate positive selection of CD4+ T lymphocytes in class II-deficient mice.

Authors:  J S Markowitz; H Auchincloss; M J Grusby; L H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

3.  Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.

Authors:  S Erdogan; M D Houslay
Journal:  Biochem J       Date:  1997-01-01       Impact factor: 3.857

4.  A statin-based inhibitor of lymphocyte function antigen-1 protects against ischemia/reperfusion-induced leukocyte adhesion in the colon.

Authors:  Min Xiu Wan; Rene Schramm; Daniel Klintman; Karl Welzenbach; Gabriele Weitz-Schmidt; Henrik Thorlacius
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

5.  Histone deacetylase 7 functions as a key regulator of genes involved in both positive and negative selection of thymocytes.

Authors:  Herbert G Kasler; Eric Verdin
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

6.  Phenotypic and functional analysis of positive selection in the gamma/delta T cell lineage.

Authors:  F B Wells; Y Tatsumi; J A Bluestone; S M Hedrick; J P Allison; L A Matis
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

7.  Adenoviral-mediated gene transfer in lymphocytes.

Authors:  R P Leon; T Hedlund; S J Meech; S Li; J Schaack; S P Hunger; R C Duke; J DeGregori
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

8.  Regulation of mu opioid receptor expression in developing T cells.

Authors:  Lily Zhang; Judith Sliker Belkowski; Tammi Briscoe; Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2012-08-25       Impact factor: 4.147

9.  Gasp, a Grb2-associating protein, is critical for positive selection of thymocytes.

Authors:  Michael S Patrick; Hiroyo Oda; Kunihiro Hayakawa; Yoshinori Sato; Koji Eshima; Teruo Kirikae; Shun-Ichiro Iemura; Mutsunori Shirai; Takaya Abe; Tohru Natsume; Takehiko Sasazuki; Harumi Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-14       Impact factor: 11.205

10.  Comparison of DNA vaccines producing HIV-1 Gag and LAMP/Gag chimera in rhesus macaques reveals antigen-specific T-cell responses with distinct phenotypes.

Authors:  Antonio Valentin; Priya Chikhlikar; Vainav Patel; Margherita Rosati; Milton Maciel; Kern-Hee Chang; Peter Silvera; Barbara K Felber; George N Pavlakis; J Thomas August; Ernesto T A Marques
Journal:  Vaccine       Date:  2009-06-17       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.